Lilly acquires Orna Therapeutics

Lilly agreed to acquire Orna Therapeutics. Reported deal value: $2.4B. Status: Announced. Sector: Biotechnology. Target headquarters context: Cambridge, Massachusetts, United States.

This page summarizes publicly available information about the transaction as of 2026-02-09. Figures and status may change as filings and press coverage update.

Eli Lilly and Co. and Orna Therapeutics , Inc. , a biotechnology company , announced Monday that they have entry into a definitive agreement for Lilly to acquire Orna for up to $2.4 billion in cash , inclusive of an upfront payment and subsequent payments upon achievement of certain clinical development milestones